We report here on the synthesis and photophysical/electrochemical properties of a series of novel starburst triarylamine-based organic dyes (S1, S2, S3, and S4) as well as their application in dye-sensitized nanocrystalline TiO2 solar cells (DSSCs). For the four designed dyes, the starburst triarylamine group and the cyanoacetic acid take the role of electron donor and electron acceptor, respectively. It was found that the introduction of starburst triarylamine group to form the D-D-pi-A configuration brought about superior performance over the simple D-pi-A configuration, in terms of bathochromically extended absorption spectra, enhanced molar extinction coefficients and better thermo-stability. Moreover, the HOMO and LUMO energy levels tuning can be conveniently accomplished by alternating the donor moiety, which was confirmed by electrochemical measurements and theoretical calculations. The DSSCs based on the dye S4 showed the best photovoltaic performance: a maximum monochromatic incident photon-to-current conversion efficiency (IPCE) of 85%, a short-circuit photocurrent density (J(sc)) of 13.8 mA cm(-2), an open-circuit photovoltage (V(oc)) of 0.63 V, and a fill factor (ff) of 0.69, corresponding to an overall conversion efficiency of 6.02% under 100 mW cm(-2) irradiation. This work suggests that the dyes based on starburst triphenylamine donor are promising candidates for improvement of the performance of the DSSCs.
The option of conjugated π-linkers
is critical for molecular
engineering toward the energy-level strategy of donor−π–acceptor
(D−π–A) sensitizers. There is always a balance
in the optimization of a π-linker. The π-conjugation should
be enlarged to expand the light-harvesting capability of sensitizers
for an increase in photocurrent; however, the oversized π-linker
also would affect seriously the photovoltage and photostability. Two
sensitizers, WS-22 and WS-23, are constructed
without or with benzothiadiazole (BTD) in a molecular skeleton, aiming
to gain insight into the effect of an auxiliary acceptor in D–A−π–A
sensitizers on the photophysical and photovoltaic performances, especially
focusing on the exploitation of the short circuit current density
(J
sc) and open circuit voltage (V
oc). Compared with the typical D−π–A
sensitizer WS-22, the incorporation of an auxiliary acceptor
of BTD in WS-23 can improve the light-harvesting ability
both in red-shifting the absorption peaks and the increment of absorption
coefficient. The predominant increase by 15.6% in light-harvesting
efficiency (LHE) of WS-23 results in a relatively higher J
sc from 13.77 (WS-22) to 16.91
mA cm–2 (WS-23). Moreover, the improvement
of the V
oc in WS-23 is originated
by a synergy contribution of the uplifting of E
CB and inhibition of charge recombination. The stepped light-induced
transient (SLIT) measurements indicate that the introduction of BTD
can negatively shift the conduction band of the TiO2 film.
For WS-23, the higher molecular dipole moment can bring forth a more effective charge
separation between donor and acceptor units, also resulting in an
increase in V
oc. The incorporated BTD
unit can increase V
oc by 57 mV, arising
from the CB edge shift of TiO2 (accounting for 40%, 23
mV) and the retarding charge recombination (accounting for 60%, 34
mV). As a consequence, WS-23 realizes an optimizing photovoltaic
efficiency (η = 8.15%), with an improvement of 36.5% with respect
to WS-22.
A novel isophorone sensitizer D-3 based on a donor-pi-acceptor system has been conveniently synthesized for highly efficient dye-sensitized solar cells, resulting in a remarkable overall conversion efficiency of 7.41% (AM 1.5, 100 mW cm(-2)) with Jsc of 18.63 mA cm(-2), Voc of 634 mV and FF of 0.63.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.